693 related articles for article (PubMed ID: 22201342)
1. HIV-associated neurological disorders: a guide to pharmacotherapy.
Tan IL; McArthur JC
CNS Drugs; 2012 Feb; 26(2):123-34. PubMed ID: 22201342
[TBL] [Abstract][Full Text] [Related]
2. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
[TBL] [Abstract][Full Text] [Related]
3. Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
Wright EJ
Curr Opin HIV AIDS; 2009 Sep; 4(5):447-52. PubMed ID: 20048710
[TBL] [Abstract][Full Text] [Related]
4. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy.
Neuenburg JK; Brodt HR; Herndier BG; Bickel M; Bacchetti P; Price RW; Grant RM; Schlote W
J Acquir Immune Defic Syndr; 2002 Oct; 31(2):171-7. PubMed ID: 12394795
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive dysfunction in the highly active antiretroviral therapy era.
Mothobi NZ; Brew BJ
Curr Opin Infect Dis; 2012 Feb; 25(1):4-9. PubMed ID: 22156897
[TBL] [Abstract][Full Text] [Related]
6. CSF penetration by antiretroviral drugs.
Eisfeld C; Reichelt D; Evers S; Husstedt I
CNS Drugs; 2013 Jan; 27(1):31-55. PubMed ID: 23160938
[TBL] [Abstract][Full Text] [Related]
7. Changing patterns in the neuropathogenesis of HIV during the HAART era.
Langford TD; Letendre SL; Larrea GJ; Masliah E
Brain Pathol; 2003 Apr; 13(2):195-210. PubMed ID: 12744473
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
Sacktor N
J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
[TBL] [Abstract][Full Text] [Related]
9. The far-reaching HAND of cART: cART effects on astrocytes.
Gonzalez H; Podany A; Al-Harthi L; Wallace J
J Neuroimmune Pharmacol; 2021 Mar; 16(1):144-158. PubMed ID: 32147775
[TBL] [Abstract][Full Text] [Related]
10. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
11. Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS.
Kumar S; Maurya VK; Dandu HR; Bhatt ML; Saxena SK
Biomol Concepts; 2018 May; 9(1):33-42. PubMed ID: 29742062
[TBL] [Abstract][Full Text] [Related]
12. HIV-associated neurocognitive disorders (HAND).
Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Gill H; Attali M; Asher I
Isr Med Assoc J; 2015 Jan; 17(1):54-9. PubMed ID: 25739180
[TBL] [Abstract][Full Text] [Related]
13. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.
Patel K; Ming X; Williams PL; Robertson KR; Oleske JM; Seage GR;
AIDS; 2009 Sep; 23(14):1893-901. PubMed ID: 19644348
[TBL] [Abstract][Full Text] [Related]
14. Interrogating the impact of combination antiretroviral therapies on HIV-associated neurocognitive disorders.
Sharma I
HIV Med; 2021 Oct; 22(9):783-790. PubMed ID: 34291558
[TBL] [Abstract][Full Text] [Related]
15. Current understanding of HIV-associated neurocognitive disorders pathogenesis.
Gannon P; Khan MZ; Kolson DL
Curr Opin Neurol; 2011 Jun; 24(3):275-83. PubMed ID: 21467932
[TBL] [Abstract][Full Text] [Related]
16. An update on the neuropathology of HIV in the HAART era.
Bell JE
Histopathology; 2004 Dec; 45(6):549-59. PubMed ID: 15569045
[TBL] [Abstract][Full Text] [Related]
17. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.
Smit TK; Brew BJ; Tourtellotte W; Morgello S; Gelman BB; Saksena NK
J Virol; 2004 Sep; 78(18):10133-48. PubMed ID: 15331746
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for the diagnosis and management of neurological complications of HIV infection.
Portegies P; Solod L; Cinque P; Chaudhuri A; Begovac J; Everall I; Weber T; Bojar M; Martinez-Martin P; Kennedy PG
Eur J Neurol; 2004 May; 11(5):297-304. PubMed ID: 15142222
[TBL] [Abstract][Full Text] [Related]
19. Neurologic Complications in Persons With HIV Infection in the Era of Antiretroviral Therapy.
Kolson D
Top Antivir Med; 2017; 25(3):97-101. PubMed ID: 28820724
[TBL] [Abstract][Full Text] [Related]
20. HIV-1-associated dementia during HAART therapy.
Aquaro S; Svicher V; Ronga L; Perno CF; Pollicita M
Recent Pat CNS Drug Discov; 2008 Jan; 3(1):23-33. PubMed ID: 18221238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
